Organon on comprehensive regulatory questions on medicinal products and medical devices as well as on corresponding distribution channels, import, pharmacovigilance, and advertising. 

Carl Zeiss Meditec in connection with a cloud-based digital health platform as well as the implementation of this health platform in an app. 

A global pharmaceutical company on issues relating to the regulation of in vitro diagnostics, in particular the placement on the market of Laboratory Developed Tests (LDTs). 

Vision Healthcare, a consumer healthcare company headquartered in Belgium with an extensive portfolio of self-care brands and over-the-counter products in several European countries, on the acquisition of 100% of the shares of AixSwiss BV, a leading provider of probiotic dietary supplements. 

Enovis Corporation on an investment in the German digital health start-up Orthopy Health GmbH. 

Global pharmaceutical companies in patent litigation cases and related pharmaceutical law and regulatory questions. 

Kyowa Kirin International (KKI) on its joint venture collaboration with global science-based, privately owned pharmaceutical company Grünenthal for KKI’s established medicines portfolio.